6 years ago

TTS Pharma Secures £10.3 Million in Series B Funding to Expand Cannabis Operations

  • TTS Pharma Limited, a UK-based company focused on the ethical cannabis market, has closed a £10.3 million Series B funding round

  • The company plans to use the funds to expand its supply chain, develop facilities, strengthen partnerships, and advance its operations in wellness, nutraceuticals, and pharmaceuticals

  • The funding also comes with the appointment of Paul Atherton as Executive Chairman

  • TTS Pharma, established in 2012, develops products and has expertise in cannabinoid extraction, separation, and manufacturing

  • The company has begun selling purified cannabis products and technologies, adhering to legal and regulatory requirements in the UK and elsewhere.

      • ProblemHealthcare

      "making cannabis cultivation, manufacturing and development more efficient and sustainable"

      Solution

      "Providing vertically integrated supply chain management for the emerging ethical cannabis market"

      Covered on